TRIMAS CORP (TRS)

US8962152091 - Common Stock

27.8  +0.27 (+0.98%)

After market: 27.8 0 (0%)

Fundamental Rating

4

Taking everything into account, TRS scores 4 out of 10 in our fundamental rating. TRS was compared to 23 industry peers in the Containers & Packaging industry. The financial health of TRS is average, but there are quite some concerns on its profitability. TRS has a expensive valuation and it also scores bad on growth.



3

1. Profitability

1.1 Basic Checks

TRS had positive earnings in the past year.
In the past year TRS had a positive cash flow from operations.
Of the past 5 years TRS 4 years were profitable.
In the past 5 years TRS always reported a positive cash flow from operatings.

1.2 Ratios

Looking at the Return On Assets, with a value of 2.97%, TRS is in line with its industry, outperforming 43.48% of the companies in the same industry.
TRS has a worse Return On Equity (6.03%) than 60.87% of its industry peers.
TRS's Return On Invested Capital of 4.64% is on the low side compared to the rest of the industry. TRS is outperformed by 65.22% of its industry peers.
The Average Return On Invested Capital over the past 3 years for TRS is below the industry average of 7.70%.
Industry RankSector Rank
ROA 2.97%
ROE 6.03%
ROIC 4.64%
ROA(3y)4.16%
ROA(5y)2.81%
ROE(3y)8.38%
ROE(5y)5.13%
ROIC(3y)5.49%
ROIC(5y)5.32%

1.3 Margins

The Profit Margin of TRS (4.48%) is comparable to the rest of the industry.
TRS's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 7.98%, TRS is not doing good in the industry: 65.22% of the companies in the same industry are doing better.
TRS's Operating Margin has declined in the last couple of years.
With a decent Gross Margin value of 23.02%, TRS is doing good in the industry, outperforming 69.57% of the companies in the same industry.
In the last couple of years the Gross Margin of TRS has declined.
Industry RankSector Rank
OM 7.98%
PM (TTM) 4.48%
GM 23.02%
OM growth 3Y8.08%
OM growth 5Y-12.76%
PM growth 3YN/A
PM growth 5Y-17.5%
GM growth 3Y-1.26%
GM growth 5Y-4.32%

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so TRS is destroying value.
The number of shares outstanding for TRS has been reduced compared to 1 year ago.
Compared to 5 years ago, TRS has less shares outstanding
TRS has a better debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 2.06 indicates that TRS is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.06, TRS is in the better half of the industry, outperforming 65.22% of the companies in the same industry.
TRS has a debt to FCF ratio of 19.29. This is a negative value and a sign of low solvency as TRS would need 19.29 years to pay back of all of its debts.
With a Debt to FCF ratio value of 19.29, TRS is not doing good in the industry: 73.91% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.63 indicates that TRS is somewhat dependend on debt financing.
TRS has a Debt to Equity ratio of 0.63. This is amongst the best in the industry. TRS outperforms 86.96% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 19.29
Altman-Z 2.06
ROIC/WACC0.63
WACC7.4%

2.3 Liquidity

TRS has a Current Ratio of 2.73. This indicates that TRS is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 2.73, TRS belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
TRS has a Quick Ratio of 1.41. This is a normal value and indicates that TRS is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Quick ratio value of 1.41, TRS belongs to the best of the industry, outperforming 82.61% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.73
Quick Ratio 1.41

3

3. Growth

3.1 Past

The earnings per share for TRS have decreased by -5.73% in the last year.
Measured over the past years, TRS shows a decrease in Earnings Per Share. The EPS has been decreasing by -0.11% on average per year.
TRS shows a small growth in Revenue. In the last year, the Revenue has grown by 3.45%.
Measured over the past years, TRS shows a small growth in Revenue. The Revenue has been growing by 4.85% on average per year.
EPS 1Y (TTM)-5.73%
EPS 3Y3.27%
EPS 5Y-0.11%
EPS growth Q2Q23.33%
Revenue 1Y (TTM)3.45%
Revenue growth 3Y5.09%
Revenue growth 5Y4.85%
Revenue growth Q2Q5.38%

3.2 Future

The Earnings Per Share is expected to grow by 13.00% on average over the next years. This is quite good.
Based on estimates for the next years, TRS will show a small growth in Revenue. The Revenue will grow by 3.13% on average per year.
EPS Next Y16.06%
EPS Next 2Y13%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.15%
Revenue Next 2Y3.13%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 15.36, the valuation of TRS can be described as correct.
Compared to the rest of the industry, the Price/Earnings ratio of TRS is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 28.83, TRS is valued a bit cheaper.
The Price/Forward Earnings ratio is 12.51, which indicates a correct valuation of TRS.
TRS's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.47, TRS is valued a bit cheaper.
Industry RankSector Rank
PE 15.36
Fwd PE 12.51

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, TRS is valued a bit more expensive than 73.91% of the companies in the same industry.
TRS's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. TRS is more expensive than 78.26% of the companies in the same industry.
Industry RankSector Rank
P/FCF 51.28
EV/EBITDA 11.64

4.3 Compensation for Growth

TRS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
TRS's earnings are expected to grow with 13.00% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.96
PEG (5Y)N/A
EPS Next 2Y13%
EPS Next 3YN/A

2

5. Dividend

5.1 Amount

With a yearly dividend of 0.60%, TRS is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.80, TRS is paying slightly less dividend.
With a Dividend Yield of 0.60, TRS pays less dividend than the S&P500 average, which is at 2.34.
Industry RankSector Rank
Dividend Yield 0.6%

5.2 History

TRS has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years2

5.3 Sustainability

TRS pays out 16.41% of its income as dividend. This is a sustainable payout ratio.
DP16.41%
EPS Next 2Y13%
EPS Next 3YN/A

TRIMAS CORP

NASDAQ:TRS (5/16/2024, 7:21:57 PM)

After market: 27.8 0 (0%)

27.8

+0.27 (+0.98%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryContainers & Packaging
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.13B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 0.6%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 15.36
Fwd PE 12.51
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.96
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.97%
ROE 6.03%
ROCE
ROIC
ROICexc
ROICexgc
OM 7.98%
PM (TTM) 4.48%
GM 23.02%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.73
Quick Ratio 1.41
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-5.73%
EPS 3Y3.27%
EPS 5Y
EPS growth Q2Q
EPS Next Y16.06%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)3.45%
Revenue growth 3Y5.09%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y